🔗 Permalink

Inventor profile of:

Wolfgang Schmidt

City:

Saffron Walden

Country:

United Kingdom

Published Applications:

Last publication date:

2018-01-18

Top Assignees for applications by Wolfgang Schmidt

The entities that hold a legal rights for patent applications filed by inventor Schmidt Wolfgang:

Janssen Pharmaceutica NV 6 Beerse, Belgium
Chiesi Farmaceutici S.p.A. 6 Parma, Italy
GALAPAGOS N.V. 3 Mechelen, Belgium

Recent patent applications by Schmidt Wolfgang

Wolfgang Schmidt from Saffron Walden, GB has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-01-18

US20180016267A1

Chemistry; metallurgy

Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

#2 | 2017-05-04

US20170119753A1

Human necessities

Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity

#3 | 2016-12-01

US20160346271A1

Human necessities

Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

#4 | 2016-08-18

US20160235734A1

Human necessities

Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity

#5 | 2015-05-21

US20150139916A1

Chemistry; metallurgy

Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

#6 | 2014-06-12

US20140163066A1

Human necessities

Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

#7 | 2012-09-13

US20120232075A1

Chemistry; metallurgy

Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases

#8 | 2011-09-08

US20110218178A1

Chemistry; metallurgy

Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases

#9 | 2011-07-21

US20110178067A1

Chemistry; metallurgy

TRIAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

#10 | 2011-04-21

US20110092497A1

Chemistry; metallurgy

Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases

#11 | 2010-11-25

US20100298300A1

Chemistry; metallurgy

Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases

#12 | 2009-05-21

US20090131446A1

Chemistry; metallurgy

Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases

#13 | 2009-04-23

US20090105242A1

Chemistry; metallurgy

Triazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases

#14 | 2009-01-08

US20090012078A1

Chemistry; metallurgy

Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases

#15 | 2008-04-17

US20080090818A1

Chemistry; metallurgy

Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases

#16 | 2007-12-06

US20070281943A1

Chemistry; metallurgy

Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases

InventorID:

797159 ⎘